Neil Woodford is unlikely to be able to offload one of his largest unlisted holdings, commentators have warned.
It is thought the manager will struggle to exit life sciences company Oxford Nanopore either through floating on the stock exchange or as part of a private debt raising fundraising before the end of the year due to the sluggish IPO market, sources told The Telegraph. RC Brown picks up third purchase in Woodford fire sale The shuttered Woodford Equity Income fund (WEIF) is slated to reopen in December but this is dependent on the manager raising the necessary levels of cash, while the Woodford Patient Capital trust is facing a debt deadline. The board of WPCT is hoping to extend a ...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes